Eesti Teadusinfosüsteem

Patentne leiutis: Live-attenuated Zika virus vaccine candidate; Omanikud: Tartu Ülikool, Loodus- ja täppisteaduste valdkond, tehnoloogiainstituut; Autorid: Andres Merits, Eva Žusinaite, Suresh Mahalingam; Prioriteedi number: No. 2018903913; Prioriteedi kuupäev: 16.10.2018.

Patentne leiutis

Live-attenuated Zika virus vaccine candidate

Live-attenuated Zika virus vaccine candidate

This invention generally relates to a codon deoptimized Zika virus genome. In particular, embodiments of the invention concern a vaccine comprising live attenuated Zika virus comprising a partly codon deoptimized viral genome, a Zika virus comprising a partly codon deoptimized viral genome, as well as their use in methods of treatment and prevention of viral infection

This invention generally relates to a codon deoptimized Zika virus genome. In particular, embodiments of the invention concern a vaccine comprising live attenuated Zika virus comprising a partly codon deoptimized viral genome, a Zika virus comprising a partly codon deoptimized viral genome, as well as their use in methods of treatment and prevention of viral infection

Lisainfo: Jane Luht Maris Astel sekretär Tartu Ülikool ettevõtlus- ja innovatsioonikeskus Lossi 3-323 7374809 maris.astel@ut.ee

16.10.2018

No. 2018903913

Muu ...

Tegemist on taotlusega seega ei ole ükski Staatus valikutest rakendatav. Kuna midagi peab valima on valitud "Kaitstud" ehkki see pole tõsi.

Australian Provisional Patent Application No. 2018903913

Austraalia patendiamet

Austraalia

Kaitstud